Amelia Martín Uranga, Associate Director of Clinical and Translational Research at Farmaindustria, explains why Spain is an international leader in clinical trials. Spain is the second country in terms of investment by the pharmaceutical industry, behind the United States. The investment exceeds €800 million for 906 clinical trials in which more than 170,000 patients are treated. More than 60% of the clinical trials are for cancer treatment. We hope you find this interesting!
